BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8083095)

  • 1. Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix.
    Pedersen D; Bentzen SM; Overgaard J
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):941-52. PubMed ID: 8083095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting radiotherapeutic complications in patients with uterine cervical cancer. The importance of latency and classification system.
    Pedersen D; Bentzen SM; Overgaard J
    Radiother Oncol; 1993 Aug; 28(2):134-41. PubMed ID: 8248554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of morbidity after external radiotherapy and intracavitary brachytherapy in 771 patients with carcinoma of the uterine cervix or endometrium.
    Yalman D; Arican A; Ozsaran Z; Celik OK; Yürüt V; Esassolak M; Haydaroglu A
    Eur J Gynaecol Oncol; 2002; 23(1):58-62. PubMed ID: 11876395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of late toxicities of patients with carcinoma of the cervix treated with radical radiotherapy: an audit from India.
    Saibishkumar EP; Patel FD; Sharma SC
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):30-7. PubMed ID: 16477917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late radiotherapeutic morbidity in patients with carcinoma of the uterine cervix: the application of the French-Italian glossary.
    Rodrigus P; De Winter K; Leers WH; Kock HC
    Radiother Oncol; 1996 Aug; 40(2):153-7. PubMed ID: 8884969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous or split-course combined external and intracavitary radiotherapy of locally advanced carcinoma of the uterine cervix.
    Pedersen D; Bentzen SM; Overgaard J
    Acta Oncol; 1994; 33(5):547-55. PubMed ID: 7917370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma of the uterine cervix. II. Lack of impact of prolongation of overall treatment time on morbidity of radiation therapy.
    Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):3-11. PubMed ID: 12118562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study.
    Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Westerveld H; Haie-Meder C; Petrič P; Mahantshetty U; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):88-95. PubMed ID: 24725693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose-rate afterloading brachytherapy in carcinoma of the cervix: an experience of 1992 patients.
    Lorvidhaya V; Tonusin A; Changwiwit W; Chitapanarux I; Srisomboon J; Wanwilairat S; Chawapun N; Sukthomya V
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1185-91. PubMed ID: 10725630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix.
    Eifel PJ; Levenback C; Wharton JT; Oswald MJ
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1289-300. PubMed ID: 7635768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables.
    Ferrigno R; Campos de Oliveira Faria SL; Weltman E; Salvajoli JV; Segreto RA; Pastore A; Nadalin W
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):695-706. PubMed ID: 12573757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.
    Ferrigno R; dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Gentil AC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1123-35. PubMed ID: 11483321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies.
    Barillot I; Horiot JC; Maingon P; Truc G; Chaplain G; Comte J; Brenier JP
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):189-200. PubMed ID: 10924989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
    Chen SW; Liang JA; Yang SN; Lin FJ
    Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.
    Tan LT; Jones B; Gee A; Kingston RE
    Br J Radiol; 1997 Dec; 70(840):1259-69. PubMed ID: 9505845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Late bladder complications following radiotherapy of carcinoma of the uterine cervix].
    Li A; Sun J; Chao H
    Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):741-3. PubMed ID: 8728921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose rate brachytherapy for carcinoma of the cervix: risk factors for late rectal complications.
    Uno T; Itami J; Aruga M; Kotaka K; Fujimoto H; Sato T; Minoura S; Ito H
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):615-21. PubMed ID: 9486611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De-escalation of the cumulative central radiation dose according to the tumor response can reduce rectal toxicity without compromising the treatment outcome in patients with uterine cervical cancer.
    Kim KH; Kim S; Kim GE; Koom WS; Kim SW; Nam EJ; Suh CO; Kim YB
    Gynecol Oncol; 2015 Dec; 139(3):439-46. PubMed ID: 26456139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.